Prompted the development of a humanized monoclonal antibody (mAb) against SLAMF
Prompted the improvement of a humanized monoclonal antibody (mAb) against SLAMF7, named elotuzumab (trade name Empliciti, Bristol-Myers Squibb). As a single agent, this drug has no powerful antimyeloma activity, but…